Revision: Oct. 22, 2025, 1:34 p.m.
Senate Health and Human Services
October 22, 2025
2025-3030s
05/05
Amendment to HB 126
Amend the bill by replacing all after the enacting clause with the following:
1 Controlled Drug Act; Sale by Pharmacist; Prescription Restrictions and Exceptions. RSA 318-B:9, IV is repealed and reenacted to read as follows:
IV. No prescription shall be filled for more than a 34-day supply upon any single filling for controlled drugs of schedules II or III, except as specified below:
(a) For schedule II or III controlled drugs that are commercially packaged for dispensing directly to the patient, such as metered sprays and inhalers, liquids packaged in bottles with calibrated droppers, and topical preparations packaged with metered dispensing pumps, may be filled for greater than a 34-day supply, but not more than 60 days, utilizing the smallest available product size, in order to maintain the dosing integrity of the commercially packaged containers.
(b) A prescription for amphetamines and methylphenidate hydrochloride may be filled for up to a 90-day supply if the prescription specifies it is being used for the treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy.
(c) Prescriptions for a topically applied androgen prescribed for the treatment of chronic low testosterone may be filled for up to a 92-day supply.
(d) Prescriptions for an injectable androgen prescribed for the treatment of chronic low testosterone may be filled for up to a 92-day supply.
2 Effective Date. This act shall take effect 60 days after its passage.
2025-3030s
AMENDED ANALYSIS
This bill clarifies exceptions to the 34-day limit on prescriptions for controlled drugs and permits a pharmacist to fill a prescription for a 92-day supply of injectable androgen prescribed for the treatment of chronic low testosterone.